Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- WalkITIndependent statistical analysis of A Walking Intervention Through Text Messaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02053259).
- Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI: Complete Statistical AnalysisIndependent statistical analysis of Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI: primary endpoint results, effect…
- WATERIndependent statistical analysis of Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02505919).
- WAVEIndependent statistical analysis of Durvalumab Long-Term Safety and Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04078152).
- Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease: Complete Statistical AnalysisIndependent statistical analysis of Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01860651).
- Web-based Smoking Cessation Program for Tribal College Students: Complete Statistical AnalysisIndependent statistical analysis of Web-based Smoking Cessation Program for Tribal College Students: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02050308).
- Weight-based Dosing in Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of Weight-based Dosing in Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02586012).
- Welcome2Independent statistical analysis of Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- WH-PACTIndependent statistical analysis of Implementation of Women's Health Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039856).
- Wheat OITIndependent statistical analysis of Oral Immunotherapy for Wheat Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01980992).
- Whey Protein Supplementation in High School Athletes: Complete Statistical AnalysisIndependent statistical analysis of Whey Protein Supplementation in High School Athletes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05589129).
- Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment: Complete Statistical AnalysisIndependent statistical analysis of Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer: primary endpoint results, effect estimate with confidence…
- With Love: Using Promotoras for a Hispanic Community Palliative Care Promotora Palliative Care: Complete Statistical AnalysisIndependent statistical analysis of With Love: Using Promotoras for a Hispanic Community Palliative Care Promotora Palliative Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Women Veterans’ Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Women Veterans' Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00734903).
- Women’s MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC: Complete Statistical AnalysisIndependent statistical analysis of Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention: Complete Statistical AnalysisIndependent statistical analysis of Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Worksite Phone Counseling for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Worksite Phone Counseling for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02730260).
- WRAPIndependent statistical analysis of Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- WtBrFemFxIndependent statistical analysis of Immediate Weight Bearing Versus Protected Weight Bearing in Supracondylar Distal Femur Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- WU197Independent statistical analysis of Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00656851).
- X-3 Polyethylene Survival Outcomes Study: Complete Statistical AnalysisIndependent statistical analysis of X-3 Polyethylene Survival Outcomes Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00493792).
- X-Seal EU Post-Market Clinical Follow-Up Protocol: Complete Statistical AnalysisIndependent statistical analysis of X-Seal EU Post-Market Clinical Follow-Up Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02406612).
- X-TOLEIndependent statistical analysis of A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- X-TRAPIndependent statistical analysis of Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- XEN1101 for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of XEN1101 for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827901).
- XEO-001/07Independent statistical analysis of Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face: primary endpoint results,…
- XERADIndependent statistical analysis of A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- XIENCE PRIME Japan Post-Marketing Surveillance (PMS): Complete Statistical AnalysisIndependent statistical analysis of XIENCE PRIME Japan Post-Marketing Surveillance (PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01721096).
- Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- XPAND-IIIndependent statistical analysis of AirXpanders AeroForm Tissue Expander System for Breast Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02504424).
- Xplore2Independent statistical analysis of Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03022708).
- Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210): Complete Statistical AnalysisIndependent statistical analysis of Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YELLOW IIIIndependent statistical analysis of Effect of Evolocumab on Coronary Plaque Characteristics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04710368).
- YES-PIndependent statistical analysis of Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- YNQIndependent statistical analysis of Yes/No Questionnaire for Aphasic Patients (YNQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257696).
- Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City: Complete Statistical AnalysisIndependent statistical analysis of Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159299).
- YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YOSEMITEIndependent statistical analysis of Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma: primary endpoint results,…
- Young Men and Media Study: Complete Statistical AnalysisIndependent statistical analysis of Young Men and Media Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04109443).
- Youth Mayo Clinic Anxiety Coach Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Youth Mayo Clinic Anxiety Coach Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02205177).
- ZACFASTIndependent statistical analysis of Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00862836).
- ZamCATIndependent statistical analysis of Zambia Chlorhexidine Application Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01241318).
- ZEALIndependent statistical analysis of Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ZEAL UNLOCKIndependent statistical analysis of A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ZENITHIndependent statistical analysis of A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH): primary endpoint results, effect estimate with confidence interval,…
- ZENITHIndependent statistical analysis of Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ZEUSIndependent statistical analysis of Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00493467).